Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Ivankovic, Tatjana (57750815700)"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think
    (2023)
    Zdravkovic, Marija (24924016800)
    ;
    Popadic, Viseslav (57223264452)
    ;
    Klasnja, Slobodan (57222576460)
    ;
    Klasnja, Andrea (58782428600)
    ;
    Ivankovic, Tatjana (57750815700)
    ;
    Lasica, Ratko (14631892300)
    ;
    Lovic, Dragan (57205232088)
    ;
    Gostiljac, Drasko (13409402200)
    ;
    Vasiljevic, Zorana (6602641182)
    Coronary microvascular dysfunction (CMD) is a clinical entity linked with various risk factors that significantly affect cardiac morbidity and mortality. Hypertension, one of the most important, causes both functional and structural alterations in the microvasculature, promoting the occurrence and progression of microvascular angina. Endothelial dysfunction and capillary rarefaction play the most significant role in the development of CMD among patients with hypertension. CMD is also related to several hypertension-induced morphological and functional changes in the myocardium in the subclinical and early clinical stages, including left ventricular hypertrophy, interstitial myocardial fibrosis, and diastolic dysfunction. This indicates the fact that CMD, especially if associated with hypertension, is a subclinical marker of end-organ damage and heart failure, particularly that with preserved ejection fraction. This is why it is important to search for microvascular angina in every patient with hypertension and chest pain not associated with obstructive coronary artery disease. Several highly sensitive and specific non-invasive and invasive diagnostic modalities have been developed to evaluate the presence and severity of CMD and also to investigate and guide the treatment of additional complications that can affect further prognosis. This comprehensive review provides insight into the main pathophysiological mechanisms of CMD in hypertensive patients, offering an integrated diagnostic approach as well as an overview of currently available therapeutical modalities. © 2023 by the authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Correlation of Dyslipidemia and Inflammation With Obstructive Sleep Apnea Severity
    (2022)
    Popadic, Viseslav (57223264452)
    ;
    Brajkovic, Milica (56115773900)
    ;
    Klasnja, Slobodan (57222576460)
    ;
    Milic, Natasa (7003460927)
    ;
    Rajovic, Nina (57218484684)
    ;
    Lisulov, Danica Popovic (57190839259)
    ;
    Divac, Anica (57750306100)
    ;
    Ivankovic, Tatjana (57750815700)
    ;
    Manojlovic, Andrea (57564177900)
    ;
    Nikolic, Novica (57564430400)
    ;
    Memon, Lidija (13007465900)
    ;
    Brankovic, Marija (57217208566)
    ;
    Popovic, Maja (57197354363)
    ;
    Sekulic, Ana (56392783700)
    ;
    Macut, Jelica Bjekic (54400683700)
    ;
    Markovic, Olivera (57205699382)
    ;
    Djurasevic, Sinisa (57211577561)
    ;
    Stojkovic, Maja (57211798088)
    ;
    Todorovic, Zoran (7004371236)
    ;
    Zdravkovic, Marija (24924016800)
    Introduction: Obstructive sleep apnea (OSA) is a serious condition linked with various metabolic disorders and associated with increased all-cause and cardiovascular mortality. Although the potential mechanisms of pathophysiological processes related to OSA are relatively well known, the data regarding the correlation between obstructive sleep apnea, dyslipidemia, and systemic inflammation are still inconclusive. Methods: The study was conducted as a retrospective cohort study including 328 patients with newly diagnosed obstructive sleep apnea during the period between April 2018, and May 2020, in University Clinical Hospital Center “Bezanijska kosa”, Belgrade, Serbia. Polysomnography was performed in all patients according to the protocol. Numerous demographic, antropometric, laboratory, and clinical data were correlated to Apnea-Hypopnea Index (AHI) as a dependent variable, with a particular review on the relation between lipid abnormalities, inflammatory parameters, and obstructive sleep apnea severity. Multivariate logistic regression model was used to assess predictors of severe OSA (AHI ≥30 per hour). Results: A total of 328 patients were included in the study. The mean age of the patients was 54.0 ± 12.5 years and more than two-thirds were male (68.8%). The majority of the patients had an AHI of at least 30 events per hour. Patients with severe OSA were more frequently male, obese, hypertensive and hyperlipidemic, and had increased neck circumference (both male and female patients). One hundred and thirty-two patients had metabolic syndrome. Patients with severe OSA more frequently had metabolic syndrome and significantly higher levels of glucose, creatinine, uric acid, AST, ALT, CK, microalbumine/creatinine ratio, triglyceride, total cholesterol, HDL, total cholеsterol to HDL‐C ratio, CRP, and ESR. In the multivariate linear regression model with AHI (≥30 per hour) as a dependent variable, of demographic and clinical data, triglycerides ≥1.7 mmol/L and CRP >5 mg/L were significantly associated with AHI≥30 per hour. Conclusion: The present study on 328 patients with newly diagnosed obstructive sleep apnea revealed significant relation of lipid abnormalities, inflammatory markers, and other clinically important data with obstructive sleep apnea severity. These results can lead to a better understanding of the underlying pathophysiological processes and open the door to a new world of potentially useful therapeutic modalities. Copyright © 2022 Popadic, Brajkovic, Klasnja, Milic, Rajovic, Lisulov, Divac, Ivankovic, Manojlovic, Nikolic, Memon, Brankovic, Popovic, Sekulic, Macut, Markovic, Djurasevic, Stojkovic, Todorovic and Zdravkovic.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Correlation of Dyslipidemia and Inflammation With Obstructive Sleep Apnea Severity
    (2022)
    Popadic, Viseslav (57223264452)
    ;
    Brajkovic, Milica (56115773900)
    ;
    Klasnja, Slobodan (57222576460)
    ;
    Milic, Natasa (7003460927)
    ;
    Rajovic, Nina (57218484684)
    ;
    Lisulov, Danica Popovic (57190839259)
    ;
    Divac, Anica (57750306100)
    ;
    Ivankovic, Tatjana (57750815700)
    ;
    Manojlovic, Andrea (57564177900)
    ;
    Nikolic, Novica (57564430400)
    ;
    Memon, Lidija (13007465900)
    ;
    Brankovic, Marija (57217208566)
    ;
    Popovic, Maja (57197354363)
    ;
    Sekulic, Ana (56392783700)
    ;
    Macut, Jelica Bjekic (54400683700)
    ;
    Markovic, Olivera (57205699382)
    ;
    Djurasevic, Sinisa (57211577561)
    ;
    Stojkovic, Maja (57211798088)
    ;
    Todorovic, Zoran (7004371236)
    ;
    Zdravkovic, Marija (24924016800)
    Introduction: Obstructive sleep apnea (OSA) is a serious condition linked with various metabolic disorders and associated with increased all-cause and cardiovascular mortality. Although the potential mechanisms of pathophysiological processes related to OSA are relatively well known, the data regarding the correlation between obstructive sleep apnea, dyslipidemia, and systemic inflammation are still inconclusive. Methods: The study was conducted as a retrospective cohort study including 328 patients with newly diagnosed obstructive sleep apnea during the period between April 2018, and May 2020, in University Clinical Hospital Center “Bezanijska kosa”, Belgrade, Serbia. Polysomnography was performed in all patients according to the protocol. Numerous demographic, antropometric, laboratory, and clinical data were correlated to Apnea-Hypopnea Index (AHI) as a dependent variable, with a particular review on the relation between lipid abnormalities, inflammatory parameters, and obstructive sleep apnea severity. Multivariate logistic regression model was used to assess predictors of severe OSA (AHI ≥30 per hour). Results: A total of 328 patients were included in the study. The mean age of the patients was 54.0 ± 12.5 years and more than two-thirds were male (68.8%). The majority of the patients had an AHI of at least 30 events per hour. Patients with severe OSA were more frequently male, obese, hypertensive and hyperlipidemic, and had increased neck circumference (both male and female patients). One hundred and thirty-two patients had metabolic syndrome. Patients with severe OSA more frequently had metabolic syndrome and significantly higher levels of glucose, creatinine, uric acid, AST, ALT, CK, microalbumine/creatinine ratio, triglyceride, total cholesterol, HDL, total cholеsterol to HDL‐C ratio, CRP, and ESR. In the multivariate linear regression model with AHI (≥30 per hour) as a dependent variable, of demographic and clinical data, triglycerides ≥1.7 mmol/L and CRP >5 mg/L were significantly associated with AHI≥30 per hour. Conclusion: The present study on 328 patients with newly diagnosed obstructive sleep apnea revealed significant relation of lipid abnormalities, inflammatory markers, and other clinically important data with obstructive sleep apnea severity. These results can lead to a better understanding of the underlying pathophysiological processes and open the door to a new world of potentially useful therapeutic modalities. Copyright © 2022 Popadic, Brajkovic, Klasnja, Milic, Rajovic, Lisulov, Divac, Ivankovic, Manojlovic, Nikolic, Memon, Brankovic, Popovic, Sekulic, Macut, Markovic, Djurasevic, Stojkovic, Todorovic and Zdravkovic.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback